Enzymatic Exploration of Alcoholic Liver Disease

Journal Title: Scholars International Journal of Biochemistry - Year 2018, Vol 1, Issue 4

Abstract

Alcoholic liver disease (ALD) is the most common liver disease in world. For many reasons, it is underestimated and underdiagnosed. Liver disease is the most likely diagnosis if the AST level is more than twice that of ALT, a ratio some studies have found in more than 80 percent of alcoholic liver disease patients. An elevated level of the liver enzyme GGT is another gauge of heavy alcohol use and liver injury. A group of blood tests called liver function tests can be used to diagnose liver disease. Other blood tests can be done to look for specific liver problems or genetic conditions. Imaging tests like ultrasound, CT scan and MRI can show liver damage. An early diagnosis is absolutely essential as alcohol is a hepatotoxin that is commonly consumed worldwide and is associated with a spectrum of liver injury including simple steatosis or fatty liver, alcoholic hepatitis, fibrosis, and cirrhosis. Alcoholic liver disease (ALD) is a general term used to refer to this spectrum of alcohol-related liver injuries. The two major end points of ALD are alcoholic liver cirrhosis and the rare and clinically-defined alcoholic hepatitis (AH). The prediction and early diagnosis of both entities is still insufficiently solved and usually relies on a combination of laboratory, clinical and imaging findings. It is not widely conceived that conventional screening tools for ALD such as ultrasound imaging or routine laboratory testing can easily overlook ca. 40% of manifest alcoholic liver cirrhosis. Non-invasive methods such as transient elastography (Fibroscan), acoustic radiation force impulse imaging or shear wave elastography have significantly improved the early diagnosis of alcoholic cirrhosis. Present algorithms allow either the exclusion or the exact definition of advanced fibrosis stages in ca. 95% of patients. The correct interpretation of liver stiffness requires a timely abdominal ultrasound and actual transaminases levels. Other non-invasive methods such as controlled attenuation parameter, serum levels of M30 or M65, susceptometry or breath tests are under current evaluation to assess the degree of steatosis, apoptosis and iron overload in these patients. Liver biopsy still remains an important option to rule out comorbidities and to confirm the prognosis namely for patients with AH.

Authors and Affiliations

Dr. Anil Batta

Keywords

Related Articles

Comparison of Biochemical Parameters in Saliva with Serum of Chronic Alcoholics: Saliva Can be Used as a Diagnostic Tool in the Future

Alcohol has always been recognized as having a significant impact on the health of the public [1]. Firstly, there has been a focus on the increasing impact of alcoholic liver disease (ALD) in the population as a result o...

The Association between Serum Calcium and Vitamin D levels in Relation To Hypertension and Type 2 Diabetes in the Tribal Population of Adilabad District

Recent evidences have shown an association between vitamin D deficiency and hypertension including diabetes mellitus. The exact underlying mechanism is obscure however vitamin D appears to be involved in regulation of th...

Cholesterol Fasting or Non Fasting? Patient Variables in Cholesterol Testing Values

Fasting for at least eight hours prior to a lipid test has been standard practice in India and internationally for many years. However, a growing body of evidence and international expert opinion suggests that a non-fast...

A Study on Renal Function Tests in Subclinical Hypo and hyperthyroid Disorders

Thyroid hormones have many important biological functions in our body. One of the major functions is control of the basal metabolic rate and calorigenesis. Thyroid dysfunction causes remarkable changes in glomerular and...

Fast, Accurate and Cost-Effective Detection and Diagnostics of Diabetes Mellitus Thanks to Using New, Patented Diagnostic Procedure and Clinical Expert Decision Support System Bio Analyst

The main aim of this study is to present a new, effective approach to diagnose Diabetes Mellitus in a timely, accurate and cost-effective manner, thanks to using technology and new, patented diagnosing procedure. This st...

Download PDF file
  • EP ID EP543525
  • DOI -
  • Views 42
  • Downloads 0

How To Cite

Dr. Anil Batta (2018). Enzymatic Exploration of Alcoholic Liver Disease. Scholars International Journal of Biochemistry, 1(4), 131-136. https://europub.co.uk/articles/-A-543525